I think he is too busy dealing with a big product ramp up and 3 OEMs negotiations. As long as disclosure remains good and execution stays on track I'm fine with less mngt time for us. Cheers
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game